Cargando…

HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana †

There are limited real-world mutational and virological outcomes data of treatment-experienced persons diagnosed with HIV-1 subtype C (HIV-1 C) who are failing Integrase Strand Transfer Inhibitor-based regimens. Requisition forms sent for HIV-1 genotypic resistance testing (GRT) between May 2015 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seatla, Kaelo K., Maruapula, Dorcas, Choga, Wonderful T., Ntsipe, Tshenolo, Mathiba, Nametso, Mogwele, Mompati, Kapanda, Max, Nkomo, Bornapate, Ramaabya, Dinah, Makhema, Joseph, Mmalane, Mompati, Mine, Madisa, Kasvosve, Ishmael, Lockman, Shahin, Moyo, Sikhulile, Gaseitsiwe, Simani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066386/ https://www.ncbi.nlm.nih.gov/pubmed/33807382 http://dx.doi.org/10.3390/v13040594

Ejemplares similares

Comparison of an in-house ‘home-brew’ and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples
por: Seatla, Kaelo K., et al.
Publicado: (2019)

Limited HIV-1 Subtype C nef 3′PPT Variation in Combination Antiretroviral Therapy Naïve and Experienced People Living with HIV in Botswana
por: Seatla, Kaelo K., et al.
Publicado: (2021)

Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2020)

HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads
por: Bareng, Ontlametse T, et al.
Publicado: (2022)

Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use
por: Maruapula, Dorcas, et al.
Publicado: (2023)

HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2020)

High Prevalence of Hepatitis B Virus Infection Among People With HIV in Rural and Periurban Communities in Botswana
por: Phinius, Bonolo B, et al.
Publicado: (2023)

Acceptability of oral HIV self-testing among female sex workers in Gaborone, Botswana
por: Shava, Emily, et al.
Publicado: (2020)

Feasibility of oral HIV self-testing in female sex workers in Gaborone, Botswana
por: Shava, Emily, et al.
Publicado: (2021)

Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana
por: Maseng, Monkgomotsi J, et al.
Publicado: (2021)

Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naïve HIV-1 Subtype C-infected patients in Botswana
por: Maruapula, Dorcas, et al.
Publicado: (2021)

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana
por: Bareng, Ontlametse T., et al.
Publicado: (2022)

Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay
por: Rantshabeng, Patricia, et al.
Publicado: (2019)

No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana
por: Mokaleng, Baitshepi, et al.
Publicado: (2023)

In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana
por: Choga, Wonderful Tatenda, et al.
Publicado: (2020)

Molecular detection of human papillomavirus (HPV) in highly fragmented DNA from cervical cancer biopsies using double-nested PCR
por: Tawe, Leabaneng, et al.
Publicado: (2018)

Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana
por: Phinius, Bonolo B., et al.
Publicado: (2023)

The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana
por: N’Guessan, Kombo F, et al.
Publicado: (2017)

Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana
por: Phinius, Bonolo Bonita, et al.
Publicado: (2020)

Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana
por: Rantshabeng, Patricia S., et al.
Publicado: (2017)

Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana
por: Mbangiwa, Tshepiso, et al.
Publicado: (2018)

Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya
por: Tawe, Leabaneng, et al.
Publicado: (2022)

Predicted broadly neutralizing antibody (bnAb) resistance and associated envelope characteristics of adults with HIV-1 seroconversion in Botswana
por: Moraka, Natasha Onalenna, et al.
Publicado: (2023)

Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana
por: Moraka, Natasha O., et al.
Publicado: (2023)

Promoter Hypermethylation Analysis of Host Genes in Cervical Cancer Patients With and Without Human Immunodeficiency Virus in Botswana
por: Tawe, Leabaneng, et al.
Publicado: (2021)

Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana
por: Mupfumi, Lucy, et al.
Publicado: (2018)

Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana
por: Mupfumi, Lucy, et al.
Publicado: (2018)

Genetic diversity of Mycobacterium tuberculosis strains circulating in Botswana
por: Mogashoa, Tuelo, et al.
Publicado: (2019)

Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2022)

Epidemiological and viral characteristics of undiagnosed HIV infections in Botswana
por: Bhebhe, Lynnette, et al.
Publicado: (2022)

Abacavir alters the transcription of inflammatory cytokines in virologically suppressed, HIV-infected women
por: MacLeod, Iain J, et al.
Publicado: (2012)

In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm
por: Anderson, Motswedi, et al.
Publicado: (2018)

Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana
por: Kotokwe, Kenanao, et al.
Publicado: (2023)

The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana
por: Maseng, Monkgomotsi J., et al.
Publicado: (2022)

HIV-exposed children account for more than half of 24-month mortality in Botswana
por: Zash, Rebecca, et al.
Publicado: (2016)

Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana
por: Phinius, Bonolo B., et al.
Publicado: (2020)

High prevalence of hepatitis delta virus among people with hepatitis B virus and HIV coinfection in Botswana
por: Baruti, Kabo, et al.
Publicado: (2023)

Five years after Treat All implementation: Botswana’s HIV response and future directions in the era of COVID-19
por: Jefferis, Keith, et al.
Publicado: (2021)

The barriers and facilitators of HIV-exposed infant testing as perceived by HIV-positive mothers in Botswana: A qualitative study
por: Karugaba, Grace, et al.
Publicado: (2022)

Estimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana community
por: Novitsky, Vlad, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o43s5ju44cab473t7qri4pjeb1